Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1381 to 1395 of 2182 results for guidelines

  1. Adding a newer anti-anginal drug to a calcium channel blocker:- What is the clinical and cost effectiveness of adding a newer anti-anginal drug (nicorandil, ivabradine or ranolazine) to a calcium channel blocker for treating stable angina?

    clinical practice and inform future updates of key recommendations in this guideline. Source guidance details Comes from guidance Stable...

    Research recommendation
    Published
    9 June 2015

  2. Carrier probability calculation models:- Further research is recommended into developing and validating models for calculating carrier probability, which incorporate additional data, such as the molecular pathology of tumours and the prevalence of mutations in different ethnic groups. [new 2013]

    Any explanatory notes(if applicable) Why this is important:- This guideline recommends offering genetic testing to people with a 10%...

    Research recommendation
    Published
    9 June 2015

  3. Safety and safeguarding:- What safeguarding practices are most effective in improving outcomes for people using services?

    Any explanatory notes(if applicable) Why it is important:- The Guideline Committee identified variation in organisational attitudes to,...

    Research recommendation
    Published
    13 October 2015

  4. Information and support:- What information and support interventions are effective to help women with endometriosis deal with their symptoms and improve their quality of lives?

    Any explanatory notes(if applicable) Why this is important:- This guideline has identified that women with endometriosis and their...

    Research recommendation
    Published
    15 October 2018

  5. Sparsentan for treating primary IgA nephropathy (TA1074)

    Evidence-based recommendations on sparsentan (Filspari) for treating primary immunoglobulin A (IgA) nephropathy in adults.

    Technology appraisal guidance
    Last updated
    9 October 2025
    View recommendations

    Sections for TA1074

  6. ColonFlag for identifying people at risk of colorectal cancer (MIB142)

    NICE has developed a medtech innovation briefing (MIB) on ColonFlag for identifying people at risk of colorectal cancer .

    Medtech innovation briefing
    Published
    12 April 2018

  7. In people with suspected COVID-19-associated pulmonary aspergillosis (CAPA), what are the most accurate tests for diagnosing the infection and when should they be done?

    Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March

    Research recommendation
    Published
    17 December 2021

  8. Is high-flow nasal oxygen effective in reducing breathlessness compared with standard care or conventional oxygen therapy for people in hospital with COVID-19 and respiratory failure when it is agreed that treatment will not be escalated beyond non-invasive respiratory support or palliative care is needed?

    Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March

    Research recommendation
    Published
    21 October 2021

  9. Smart Peak Flow for monitoring asthma (MIB282)

    NICE has developed a medtech innovation briefing (MIB) on Smart Peak Flow for monitoring asthma .

    Medtech innovation briefing
    Published
    11 January 2022

  10. Chronic conditions:- What is the prevalence of disease in the UK prison population?

    explanatory notes(if applicable) Why this is important:- At the time this guideline was published (November 2016), it was estimated that...

    Research recommendation
    Published
    16 November 2017

  11. What is the effectiveness and cost effectiveness of a trial of hydrolysed formula in formula‑fed infants with frequent regurgitation associated with marked distress?

    and/or GORD has not responded to the initial management outlined in this guideline (up to and including alginates). Source guidance...

    Research recommendation
    Published
    15 November 2019

  12. Evidence summaries: new medicines – Interim process statement (PMG1)

    This interim process statement sets out to guide the development of 'Evidence summaries: new medicines' (ESNMs). It provides an overview of the key process principles and describes all stages of the development of ESNMs

  13. Effective interventions for addressing child abuse and neglect in the UK:- What interventions, approaches and methodologies provided by social care and voluntary sectorservices are effective and cost effective in the UK to prevent the recurrence of child abuse and neglect, and to improve the wellbeing of children, young people and families?

    applicable) Why this is important:- The evidence reviewed for this guideline on the effectiveness of interventions to address abuse and...

    Research recommendation
    Published
    18 October 2018

  14. Surveillance programmes for people at increased risk of colorectal cancer:- How effective are colonoscopic surveillance programmes in improving overall survival and cancer-related survival in people at increased risk of colorectal cancer?

    differential effects associated with risk category (as defined in this guideline). Source guidance details Comes from guidance Colorectal

    Research recommendation
    Published
    9 June 2015

  15. Interventions:- In the UK, which activity-based interventions are most effective and cost effective at protecting older people who are at risk of a decline in their independence and mental wellbeing?

    measure the impact of interventions would inform future updates of the guideline. Source guidance details Comes from guidance Older...

    Research recommendation
    Published
    25 January 2016